Astria Therapeutics
ATXS
ATXS
102 hedge funds and large institutions have $811M invested in Astria Therapeutics in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
28% more funds holding
Funds holding: 80 → 102 (+22)
2.41% more ownership
Funds ownership: 102.58% → 104.98% (+2.4%)
Holders
102
Holding in Top 10
3
Calls
$51M
Puts
$8.72M
Top Buyers
| 1 | +$74.3M | |
| 2 | +$62.1M | |
| 3 | +$34.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$23.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$22.5M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$12.1M | |
| 3 | -$8.74M | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$8.67M |
| 5 |
ACM
Altium Capital Management
New York
|
-$8.27M |